Acromesomelic chondrodysplasias (ACDs) are characterized by disproportionate shortening of the appendicular skeleton, predominantly affecting the middle (forearms and forelegs) and distal segments (hands and feet). Here, we present two consanguineous families with missense (c.157T4C, p.(C53R)) or nonsense (c.657G4A, p.(W219*)) mutations in BMPR1B. Homozygous affected individuals show clinical and radiographic findings consistent with ACD-type Grebe. Functional analysis of the missense mutation C53R revealed that the mutated receptor was partially located at the cell membrane. In contrast to the wild-type receptor, C53R mutation hindered the activation of the receptor by its ligand GDF5, as shown by reporter gene assay. Further, overexpression of the C53R mutation in an in vitro chondrogenesis assay showed no effect on cell differentiation, indicating a loss of function. The nonsense mutation (c.657G4A, p.(W219*)) introduces a premature stop codon, which is predicted to be subject to nonsense-mediated mRNA decay, causing reduced protein translation of the mutant allele. A lossof-function effect of both mutations causing recessive ACD-type Grebe is further supported by the mild brachydactyly or even non-penetrance of these mutations observed in the heterozygous parents. In contrast, dominant-negative BMPR1B mutations described previously are associated with autosomal-dominant brachydactyly-type A2.
INTRODUCTION
Osteochondrodysplasias are a clinically and genetically heterogeneous group of hereditary skeletal disorders. 1 Among these, acromesomelic chondrodysplasias (ACDs) constitute a rare subgroup characterized by short stature, severely shortened limbs, and hand/foot malformations. The severity of limb abnormalities increases in a proximo-to-distal gradient with hands and feet being most severely affected, showing brachydactyly and/or rudimentary fingers. The group of ACDs are classified into five subgroups according to the Nosology and Classification of Genetic Skeletal Disorders: 2 Acromesomelic dysplasia-type Maroteaux (MIM 602875), Grebe dysplasia (Grebe type, MIM 200700 and Hunter Thompson type, MIM 201250), Fibular hypoplasia and complex brachydactyly (Du Pan, MIM 228900), acromesomelic dysplasia with genital anomalies (MIM 609441) and Acromesomelic dysplasia Osebold-Remondini type (MIM 112910). Grebe dysplasia and Du Pan syndrome share an autosomal recessive inheritance pattern and are caused by homozygous or compound heterozygous mutations in growth and differentiation factor 5 (GDF5; MIM *601146).
GDF5 is a member of the TGF-b superfamily belonging to the subgroup of bone morphogenetic proteins (BMPs). GDF5 binds extracellular to transmembrane serine threonine kinases such as BMPR1A and BMPR1B, with a preference for BMPR1B. 3 All reported mutations in GDF5 associated with ACD are caused by a homozygous functional loss of GDF5, which is caused by either deletions, duplications, or insertions leading to a premature translational stop or caused by point mutations targeting the cleavage site or the mature domain of GDF5, thereby compromising its regular function. [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Interestingly, one individual with a homozygous mutation in BMPR1B has been reported presenting with a subtype of ACD with additional genital anomalies, 14 implicating that mutations in the ligand and its receptor can cause similar phenotypes. Heterozygous carriers of dominant-negative mutations in BMPR1B are usually affected by brachydactyly-type A2 (BDA2; MIM number 112600), which is characterized by a shortened middle phalanx of the index finger and variable clinodactyly of the fifth finger. 15 In contrast, carriers of heterozygous mutations in the ligand, GDF5, are usually affected by brachydactyly-type C (MIM number 113100), 16, 17 a condition characterized by brachymesophalangy of index, middle, and little fingers as well as shortening of the first metacarpal. Ring fingers are only mildly affected and hyperphalangy of the index and middle fingers might occur. 9, [18] [19] [20] However, clinical phenotypes resulting from heterozygous BMPR1B and GDF5 mutations are variable and also show overlapping features. 21, 22 Here we present two consanguineous families segregating as yet unreported mutations in BMPR1B (c.157T4C, p.(C53R) and (c.657G4A, p.(W219*)) with a total of three affected individuals carrying the respective mutations in a homozygous state. Both mutations are proposed to cause a loss of function of BMPR1B.
MATERIALS AND METHODS

Clinical investigation and molecular analyses
All clinical investigations were conducted in accordance with the Declaration of Helsinki principles. Informed consent was obtained for genetic analysis. Genomic DNA was extracted from peripheral blood samples by standard methods. With regard to the ACD phenotype, we first performed mutation screening of GDF5 (NM_000557.2) and subsequently of BMPR1B (NM_001256794.1). The coding regions of GDF5 and BMPR1B as well as the flanking intronic sequences were amplified by standard PCR protocols. The primer sequences and PCR conditions for the molecular testing can be found elsewhere (GDF5; 23 BMPR1B 15 ). Sequencing was done using the ABI Prism BigDye Terminator Sequencing Kit (Applied Biosystems, Life Technologies, Foster City, CA, USA) with PCR primers used as sequencing primers. Products were evaluated on an automated capillary sequencer (Applied Biosystems 3730).
Obtained sequence variant information was submitted to the Leiden Open Variation Database (https://www.grenada.lumc.nl/LOVD2/mendelian_genes/ home.php?select_db=BMPR1B).
Sequence alignment and structural data
Amino-acid sequences of the ligand-binding domain (LBD) of the seven human TGF-b-type I receptors as well as chicken and mouse orthologs of BMPR1B were aligned using Clustal Omega 24, 25 (http://www.ebi.ac.uk/ Tools/services/web/toolform.ebi?tool=clustalo) and colored using CHROMA 26 (http://www.llew.org.uk/chroma/).
Modeling of the BMPR1B-mutant C53R was performed using the BMPR1B coordinates of the crystal structure of GDF5 bound to wild-type BMPR1B (PDB entry 3EVS). 27 First, the disulfide bond involving cysteine residues 32 and 53 of BMPR1B was removed and C53 was replaced by an arginine residue using the ProteinDesign tool of the software package Quanta2008 (Accelrys, Inc., San Diego, CA, USA). The resulting model of C53R was then refined by energy minimization using the all-hydrogen force field of CHARMM27 and employing only geometrical energy terms. As the charged side chain of the introduced arginine at position 53 is almost completely buried inside the hydrophobic core of the BMPR1B, further energy minimization and short (50 ps) in vacuo molecular dynamics simulations were performed using the CHARMM27 force field described above but employing also electrostatic energy terms using a distance-dependent treatment of the coulomb term. Images of the three-dimensional structure of a BMPR1B-GDF5 complex were based on the PDB-file 3EVS 27 rendered by PyMOL Molecular Graphics System, Schrödinger, LLC (Portland, OR, USA).
Cloning of expression constructs
The coding sequences of murine Bmpr1b and human GDF5 were cloned into the shuttle vector pSLAX13. 28 Murine Bmpr1b in pSLAX13 was used as a template for in vitro mutagenesis to introduce the homologous mutation C53R, to delete the LBD (dLBD), or to insert a hemagglutinin (HA) tag. Primers for mutagenesis are available in Supplementary 
Luciferase reporter gene assay
NIH/3T3 cells were seeded in a 96-well plate and co-transfected using Lipofectamine 2000 (Invitrogen, Life Technologies) at about 70% confluency with pCS2 þ expression constructs of Bmpr1b wt , Bmpr1b C53R , Bmpr1b dLBD , GDF5, BRE luciferase reporter construct 29 and the Renilla luciferase vector pRL-TK (Promega, Madison, WI, USA), which served as an internal control for transfection efficiency. Cells were cultivated in DMEM 4.5 g/l glucose (Lonza) supplemented with 1% FBS superior (Biochrom AG), 2 mM L-glutamine (Lonza), penicillin/streptomycin (Lonza) for 42 h after transfection and subsequently collected and lyzed in potassium phosphate buffer (9 mM potassium dihydrogen phosphate, 91 mM dipotassium phosphate, 0.2% Triton-X-100). Dual luciferase activity was determined as described previously 30 using Mithras LB 940 (Berthold Technologies GmbH & Co. KG, Bad Wildbad, Germany).
Micromass cultures
The coding sequence of chicken BMPR1B in pSLAX13. 15 was used as a template for in vitro mutagenesis to introduce the homologous mutation C53R and dLBD. Primers for mutagenesis are available in Supplementary Table 1 . Inserts were subcloned into the avian-specific retroviral construct RCASBP(A) via ClaI. 31 Production and concentration of viral supernatant was performed as described. 32 Fertilized chicken eggs (VALO BioMedia GmbH, OsterholzScharmbeck, Germany) were incubated at 37.5 1C in a humidified egg incubator for B4.5 days. Micromass cultures were isolated from limb buds of Hamburger Hamilton stage 23-24 33 as described, with minor modifications. 15 Micromass cultures were plated at a density of 2 Â 10 5 cells per 12 ml drop in the middle of a 24-well tissue-culture plate. Infection was performed with a titer of 1 Â 10 7 plaque-forming units of the concentrated RCAS viral supernatants, as described. 28 Empty RCAS virus was used as a control. Cells were allowed to attach for 2 h in a humidified atmosphere of 5% CO 2 at 39 1C and then complemented with DMEM-F12 (Biochrom AG) culture medium supplemented with 10% FBS superior (Biochrom AG), 0.2% chicken serum (Sigma-Aldrich), L-glutamine (Lonza), penicillin/streptomycin (Lonza). The culture medium was replaced every 2 days. Micromass cultures were washed twice with PBS, fixed with Kahles' Fixative (28.9% ethanol, 0.37% formaldehyde, 3.9% acetic acid), and stained with 0.05% Alcian Blue (SigmaAldrich) in 0.1 M HCl at day 7. Quantification of the staining was achieved by extraction with 6 M guanidine hydrochloride (Carl Roth GmbH þ Co. KG, Karlsruhe, Germany) overnight at RT. Dye concentration was determined spectrophotometrically at 595 nm.
RESULTS
Family I
We report on a 2-year-old female ( Figure 1Aa ) whose Lebanese parents are healthy first cousins. The first child of the couple died shortly after birth, probably because of an infectious disease. Both parents are of normal height (mother: 163 cm, father: 173 cm). The family history is otherwise unremarkable (pedigree scheme in Figure 1Ab ).
The patient presented with disproportionate short stature (height: 76 cm À4SD) because of severe acromesomelic limb shortening (Figure 1Aa ). The trunk was of normal length. Her hands showed marked shortening of digits and pronounced radially deviation of fingers. All fingernails were present (Figure 1Ac-f) . Dimpling of the skin was present over the anterior aspect of the shin, at the apex of the site of anteromedial bowing. The fibulae were not palpable. Valgus instability of the ankle joints was evident. The feet were small and broad. All toes were short and functionless with constrictions at their bases and all toenails were present (Figure 1Ag and h) .
On X-ray examination, pelvis and femora appeared normal. Tibiae were shortened and severely bowed, and fibulae were absent resulting in bilateral dislocation of the tibiotalar joints (Figure 1Aj ). Bilateral shortened ulnae, mildly bowed radii, and small ossification centers of the radial epiphyses were observed. One ossified carpal bone was detected (Figure 1Am and n). The patient had absent 1st metacarpals, slender 2nd metacarpals, clumsy and shortened 3rd-5th metacarpals as well as absence of the proximal thumb phalanx and the proximal and middle phalanges of the 5th fingers. Fingers 2-4 appeared to have only two phalangeal bones with very small proximal phalanges (Figure 1Ai ). In the feet, talus, calcaneus, and possible ossification centers of the ossa navicularia were visible, all metatarsals were present, and all distal phalanges of the feet were hypoplastic. On the left side, very small ossification centers of the phalanges of the 3rd and 4th toe were visible (Figure 1Ak and l) .
Ultrasound examination of the abdomen showed a normal uterus; the ovaries could not be evaluated because of bowel gas superposition. Ultrasound examination of the heart was normal. Hearing and ophthalmologic examination were also normal.
The mother showed mild BDA2 with shortened middle phalanges of the 2nd and 5th fingers and toes ( Supplementary Figure 1Aa-c) . The father did not show any abnormalities ( Supplementary  Figure 1Ad-f) . 
Family II
The second family originates from Pakistan; the parents are healthy first cousins and the two affected brothers are aged 15 ( Figure 1Ba ) and 19 years (Figure 1Bg ), respectively. Both parents presented with short stature (mother: 150 cm; father: 145 cm). The family history is otherwise unremarkable (pedigree Figure 1Bb) . The patients also presented with disproportionate short stature because of severe acromesomelic limb shortening ( Figure 1Ba and g) ; the younger brother was 119 cm tall ( À6SD) and the older brother was 134 cm tall ( À5.6SD). The hands of both brothers showed marked shortening of digits and mild radial deviation of fingers with all fingernails being present (Figure 1Bc and j) . The fibulae were not palpable. Valgus instability of the ankle joints was evident. The feet were small and broad with all toes being short and functionless with constrictions at their bases and all toenails being present (Figure 1Bd  and k) .
On X-ray examination, tibiae were shortened but not bowed (Figure 1Bg and k) . The fibulae were absent resulting in bilateral dislocation of the tibiotalar joints (Figure 1Bf and h) . Bilateral shortened ulnae but no bowing of the radii was observed. Carpal bones were deformed and there were carpal fusions in both affected brothers and additional fusions of the 2nd and 3rd metacarpals in the older brother. Metacarpals were shortened with the absence of 1st metacarpals, and short and deformed proximal and middle phalanges of the fingers were observed with the absence of the proximal phalanx of the index fingers (Figure 1Be and i) . In contrast to the affected girl from family I, in both brothers a small proximal phalanx of the thumbs as well as a small middle phalanx of the 5th fingers were present. In the feet, talus, calcaneus, and possible remnants of some ossa navicularia were visible and all metatarsals were present. All distal phalanges of the feet were hypoplastic; some mislocalized middle or proximal phalanges seemed to be present (Figure 1Bf and h) .
The parents presented with short stature and the father with mild generalized brachydactyly (Supplementary Figure 1; mother: Ba-c; father: Bd-f).
For a summary of phenotypic features and comparison of the patients presented here together with the patient from Demirhan et al, 14 see Table 1 .
Molecular analysis results
In both families, mutations in GDF5 were excluded and subsequent sequencing of the BMPR1B gene revealed a homozygous singlenucleotide exchange in family I: c.157T4C, p.(C53R), which has not Figure 4 BMPR1B-mutant C53R has no dominant-negative effect on in vitro chondrogenesis. Chicken micromass cultures were infected with either empty viral vector or BMPR1B (wt, C53R, dLBD or the BDA2-associated dominant-negative mutation I200K). Micromass cultures were stained with Alcian blue after 7 days of culturing to visualize cartilage formation. Cartilaginous matrix production of cultures expressing, BMPR1B C53R and BMPR1B dLBD was not altered in comparison with BMPR1B WT , whereas cultures expressing the BDA2 mutation BMPR1B I200K exhibited a strong inhibition of chondrogenesis. Alcian blue staining of chicken micromass cultures was quantified by extraction and photometric quantification at 595 nm. All values are represented as mean±SD of four replicates from one representative of three independent experiments. Two-tailed Student's t-test was performed. Significant differences in comparison with BMPR1B WT are given as *Po0.05, **Po0.01, ***Po0.001, or not significant (NS).
been reported in the literature to date. The mutation was detected in a heterozygous state in both parents. In family II, a homozygous nonsense mutation in BMPR1B was detected in both affected brothers: c.657G4A, p.(W219*), which also has not been reported in the literature to date. This mutation was again detected in a heterozygous state in both parents.
BMPR1B mutations (p.(C53R); p.(W219*)) are predicted to cause a loss of function by different mechanisms The human BMPPR1B gene is located on chromosome 4 and consists of 10 coding exons. The protein consists of 502 amino acids and contains four functional domains: a LBD, a single-pass transmembrane domain, a glycine-serine-rich-box and a kinase domain (KD; Figure 2a ). The nonsense mutation c.657G4A, p.(W219*) introduces a premature stop codon within the KD located in coding exon 6 of 10 of BMPR1B and is therefore predicted to activate the nonsensemediated mRNA decay machinery. 34 The missense mutation c.157T4C, p.(C53R) is located in coding exon 2 in the LBD and targets 1 of 10 conserved cysteines normally forming 5 distinct disulfide bridges (C32-C53, C34-C38, C47-71, C81-C95, C96-C102), which are essential for the correct folding of the extracellular domain of the receptor (Figure 2a-c) . 27 C53 is completely buried inside a hydrophobic core. An exchange of this residue by an arginine also places the polar and charged side chain inside the hydrophobic core, which very likely causes a strong electrostatic repulsion because of its shielding from water and the lack of neutralizing negatively charged residues nearby. This likely causes a partial unfolding of the extracellular LBD of BMPR1B (Figure 2d-f ).
BMPR1B C53R is only partially translocated to the cell membrane BMPR1B is a transmembrane receptor mainly located at the cell surface. In order to study whether an altered structure of the LBD caused by the C53R mutation influences its localization, HA-tagged mouse Bmpr1b constructs were expressed in NIH/3T3 cells and stained extracellularly with a HA-specific antibody. Immunofluorescence staining showed that HA-BMPR1B wt and HA-BMPR1B C53R as well as an artificially designed construct carrying a deletion of the LBD, HA-BMPR1B dLBD , are all located at the cell membrane (Figure 3a) . Notably, fluorescence intensity of the extracellular staining of cells expressing HA-BMPR1B C53R was reduced as compared with cells expressing HA-BMPR1B wt or HA-BMPR1B dLBD , which is not the case when HA-BMPR1B is stained on permeabilized cells, detecting also intracellular proteins (Supplementary Figure 2) . Although HA-BMPR1B C53R is processed and can translocate to the cell surface in our overexpression studies, the efficiency of these processes might be reduced.
GDF5-dependent receptor activation is lost in BMPR1B C53R
BMPR1B-mediated signaling can be activated by ligands, such as various BMPs and GDF5, which has a very high affinity for BMPR1B. 3, 27 We tested whether BMPR1B C53R can mediate GDF5-dependent signaling with a BMP responsive luciferase (BRE) reporter assay. NIH/ 3T3 cells were transiently co-transfected with a BRE luciferase reporter and expression constructs of either BMPR1B wt , BMPR1B C53R , or BMPR1B dLBD . In the absence of exogenously expressed ligand, a slight activation of the luciferase signal was observed for BMPR1B wt (Figure 3b ). When BMPR1B wt was coexpressed with GDF5, there was a prominent increase in the luciferase signal, which was not observed in cells co-expressing BMPR1B C53R and GDF5 (Figure 3b ). Similar to BMPR1B dLBD , which lacks the binding site for GDF5, the signal activity of BMPR1B C53R did not significantly differ from cells, which were transfected with an empty vector control (Figure 3b) . Thus, BMPR1B C53R was not able to mediate BMP signaling induced by GDF5.
BMPR1B mutation C53R has no dominant-negative effect on in vitro chondrogenesis We further studied the effect of the mutation C53R on BMPR1B by analyzing its effect on chondrogenic differentiation in vitro using the chicken micromass culture system. 35 Previously reported point mutations in BMPR1B associated with BDA2 showed a dominantnegative effect on chondrogenesis, when overexpressed in this system. 15, 21 RCASBP(A) virus expressing the chicken orthologs of BMPR1B wt , BMPR1B C53R , BMPR1B dLBD , and the BDA2-associated dominant-negative mutant BMPR1B I200K . 15 or empty virus as a control were used to infect micromass cultures. After 7 days, extracellular matrix production was evaluated by Alcian blue staining of proteoglycans in the formed cartilaginous matrix (Figure 4) . When comparing the degree of chondrogenic differentiation of micromass cultures expressing BMPR1B wt , BMPR1B C53R , or BMPR1B dLBD with control cultures, no significant differences were observed. As expected, micromass cultures expressing the BDA2-associated mutant BMPR1B I200K hardly displayed any Alcian blue staining, which indicates a strong dominant-negative effect on chondrogenic differentiation (Figure 4) . In contrast to the BDA2-associated mutation BMPR1B I200K , the ACD-associated mutation BMPR1B C53R seemed rather to constitute a loss-of-function mutant and not eliciting a dominant-negative effect.
DISCUSSION
All three patients with homozygous BMPR1B mutations reported here show a severe form of limb malformation consisting of bilateral aplasia of the fibula, severe brachydactyly, and fusion of carpal/tarsal bones as similarly seen in other ACDs. The female patient with the c.157T4C, p.(C53R) missense mutation additionally presented with bowing of tibiae and radii, which was not present in the two affected brothers with the c.657G4A, p.(W219*) nonsense mutation. For both mutations, we propose a loss-of-function mechanism. The missense mutation C53R disrupts one of five highly conserved disulfide bridges within the extracellular domain of BMPR1B. The disulfide bonds are important for folding and stability of the protein. 27 Short molecular dynamics simulation of BMPR1B carrying the C53R mutation employing a force field handling with electrostatic energy terms indicates a severe misfolding of the extracellular domain because of the unbalanced charge of the arginine residue buried into the hydrophobic core of the LBD of BMPR1B, which implicates a loss-of-function pathomechanism. This hypothesis was supported by our overexpression studies where membrane localization of the mutated receptor BMPR1B C53R was still observed, albeit without activation by the high-affinity ligand GDF5 in reporter gene analysis. It is noteworthy that the point mutation C53R had the same effect as a mutant Bmpr1b construct missing the entire LBD. It is possible that at a lower endogenous expression level, the mutated protein is degraded rapidly, as a free cysteine and a missing central disulfide bond might trigger proteasomal degradation during endoplasmic reticulum control (for review see Ellgaard et al 36 ) . Moreover, our data indicate that even receptors with membrane localization can be functionally inactive. This is also supported by our overexpression experiment using the micromass culture system, where BMPR1B C53R had no negative effect on chondrogenic differentiation, unlike the BDA2-associated dominant-negative BMPR1B I200K mutation. 15 BMPR1B I200K might act as a ligand sink by binding BMPs without initiation of signal transduction, whereas BMPR1B C53R does not bind ligands. Therefore, we propose a loss of function rather than a dominant-negative pathomechanism for the ACD-associated C53R mutation.
The nonsense mutation c.657G4A, p.(W219*) most likely fails to yield functional protein, as the transcripts encoded are likely subject to the nonsense-mediated RNA decay. So far, homozygous mutations in BMPR1B have only once been shown to cause a subtype of ACD with additional genital anomalies caused by a homozygous 8 bp deletion (c.361_368delGGACCTAT), which is located in the extracellular domain of the BMPR1B protein. 14 This mutation is also proposed to result in a loss of function because of a frameshift and premature stop codon followed by nonsense-mediated RNA decay. 14 This patient showed uterus hypoplasia and displayed ovarian dysfunction resulting in hypergonadotropic hypogonadism. In contrast, the uterus of our only female patient carrying the homozygous missense mutation c.157T4C, p.(C53R) appeared normal, but ovaries could not be evaluated by ultrasound examination. Therefore, her phenotype does not seem to differ from the other GDF5-associated ACD phenotypes.
Interestingly, heterozygous mutation carriers presented in this paper showed no classical BDA2 phenotype. Only the mother of our female patient with the missense mutation showed a mild form BDA2, whereas the father in family II presented with mild generalized brachydactyly. Moreover, the heterozygous BMPR1B mutation carriers in the family described by Demirhan et al 14 did not show any signs of brachydactyly. Thus, we propose a loss-of-function pathomechanism for homozygous BMPR1B mutations causing ACD, whereas BDA2 is caused by heterozygous dominant-negative mutations in BMPR1B. 15, 21 These findings widen the phenotypic spectrum of ACD caused by homozygous BMPR1B mutations and may help in ACD diagnosis.
